What's in Institut Pasteur de Tunis's pipeline?

Institut Pasteur de Tunis has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Institut Pasteur de Tunis's portfolio?

Top competitors by shared drug class: GlaxoSmithKline, Jiangsu Province Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, China National Biotec Group Company Limited, Helsinki University Central Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/institut-pasteur-de-tunis.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Institut Pasteur de Tunis — Portfolio Competitive Intelligence Brief

Institut Pasteur de Tunis pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
CoronaVac/BNT162b2	CoronaVac/BNT162b2	phase 3	vaccine	SARS-CoV-2 spike protein	Immunology / Infectious Disease
CoronaVac/CoronaVac	CoronaVac/CoronaVac	phase 3	Inactivated viral vaccine	SARS-CoV-2 spike protein and other viral antigens	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

GlaxoSmithKline · 2 shared drug classes
Jiangsu Province Centers for Disease Control and Prevention · 2 shared drug classes
Centers for Disease Control and Prevention · 2 shared drug classes
China National Biotec Group Company Limited · 2 shared drug classes
Helsinki University Central Hospital · 2 shared drug classes
Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 shared drug classes
Boryung Pharmaceutical Co., Ltd · 2 shared drug classes
Medical University of Vienna · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Institut Pasteur de Tunis:

Cite this brief

Drug Landscape (2026). Institut Pasteur de Tunis — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/institut-pasteur-de-tunis. Accessed 2026-05-15.